Cost effectiveness of treating cancer in Africa

On 21 November 2013 an International Workshop on Cost Effectiveness of Treating Cancer in Africa.

Date: 21 November 2013
Venue: Mkhomazi 1 room at Hilton Durban Hotel
Time: 08h30 – 16h00

This workshop is open to all AORTIC delegates. It is jointly organized by African colleagues from Senegal, Zimbabwe, Rwanda and South Africa and is intended to be a first step in creating a network of institutions that will collaborate on cancer research and economic evaluations in Africa.

The economic impact of cancer interventions will be discussed and the collaborators will come up with a strategy on research collaboration and capacity building.

Registration is free for AORTIC delegates! Please send short abstracts/contributions for possible inclusion.

Contact Person: Prof DC Stefan
Email: sunacza

Thursday 21 November 2013

08:30-09:00 Registration
09:00-09:10 Welcome
DC Stefan (Chair: Organizing Committee) & Dr F Ntaganda (co-chair)
09:10-09:20 Address JM Dangou -WHO Africa
09:20-09:30 Address by President of AORTIC
A Elzawawy

Chairs: JM Dangou, A Elzawawy

09:30-09:45 Global cancer burden with emphasis on Africa
Freddie Bray IARC, Lyon
09:45-09:55 Childhood cancer in Africa – today and tomorrow
DC Stefan, South Africa
09:55-10:20 How to calculate the cost and cost effectiveness of cancer treatment in Africa
S Horton, Canada
10:20-10:30 Cost effectiveness of cancer therapy: Emerging evidence of relevance in low- and middle-income countries
CK Williams, Canada

Cost of cancer treatment in:

10:30-10:40 Rwanda
F Ntaganda, Rwanda
10:40-10:50 Senegal (GFAOP)
C Moreira, Senegal
10:50-11:00 Uganda: Challenges of treatment of BL
C Casper, USA
11:00-11:30 Tea / Coffee

Chairs: S Horton, F Ntaganda

Cost of cancer care:

11:30-11:40 Zimbabwe
I Chitsike, Zimbabwe
11:40-11:50 Malawi
S Gupta, Canada
11:50-12:00 South Africa
A Van Zyl, South Africa
12:00-12:10 Template for cost analysis and cost effectiveness: which variables to use?
C Kay, South Africa
12:10-12:30 Parallel discussion groups: Coordinated by Prof A Elzawawy
Eastern Africa, Northern Africa, Southern Africa, Western Africa
12:30-13:00 Feedback session from discussion groups (5 minutes per group)
13:00-14:00 Lunch

Chairs: I Chitsike, C Moreira

14:00-14:30 Cost and availability of commonly used chemotherapeutic agents- interaction with pharmaceutical companies (GSK- Eva Gubern Anfruns , Roche, Novartis- Franck Mournier)
14:30-14:40 Correlation of survival with cost (Hodgkin lymphoma, nephroblastoma, Kaposi and Burkitt lymphoma) - South African calculations –
Dr G De Bruin, South Africa
14:40-14:50 The African childhood tumour: nephroblastoma survival globally
Prof N Graf, Germany
14:50-15:00 Childhood cancer awareness – CHOC: The role of parents in South Africa and Africa
Mr F Peenz, South Africa
15:00-15:15 Implementation of Cancer Care Services in Rwanda
K Lenny, Rwanda
15:15-15:45 Establishing a working group to study the “Cost of cancer care and cost effectiveness in Africa”
All participants
15:45-16:00 Closing remarks
16:00-16:30 Tea / Coffee

Key Dates

Abstract submission deadline:
Closed
Bursary application deadline:
Closed
AORTIC 2013 Pre Conference Workshops:
Wednesday 20 – Thursday 21 November 2013
AORTIC 2013:
Thursday 21 - Sunday 24 November 2013